KGW-TV profiles Lorna Day and The Sam Day Foundation, which she created to honor her son's memory and advance childhood cancer research. The foundation is holding their annual Buddy Run on Saturday, May 18, at Doernbecher Children's Hospital.

The Columbia Memorial Hospital-Oregon Health & Science University Health Urology Clinic now offers men with prostate cancer targeted positron emission tomography imaging with Pylarify, an imaging agent approved by the Food and Drug Administration to identify suspected metastasis or a return of prostate cancer.

In a podcast interview with OncLive On Air, Shivaani Kummar, M.D., discusses the ongoing investigation of the first-in-class p53 therapy rezatapopt for patients with mutated advanced solid tumors. Kummar says: “I’ve been doing drug development for over 20 years, and I find that this point is one of the most exciting times in this field as we now have the ability to specifically design molecules against molecular targets within cancer cells as well as a slew of different types of agents that target the tumor microenvironment and the immune cells.”

An OHSU study finds about 79% of clinical trial participants with leber congenital amaurosis experienced measurable improvement after receiving experimental, CRISPR-based gene editing: “This [is] a blinding disease with no treatments ... an enormous burden on patients [due] to their vision loss,” says Mark Pennesi, M.D., Ph.D.

OHSU study finds combined cannabis and nicotine use during pregnancy is associated with significantly higher risk of poor health outcomes for newborns compared with use of either substance alone.

OHSU study finds combined cannabis and nicotine use during pregnancy is associated with significantly higher risk of poor health outcomes for newborns compared with use of either substance alone.

As the FDA considers a requirement for blood banks to use a new test that can detect the parasites that cause malaria in certain donors’ blood, an advisory committee favors selective testing based on certain criteria over testing all donors: “It’s such a low incidence of disease, and it’s treatable,” said Richard Scanlan, M.D.

In a Source Weekly (Bend) article about the Community Belonging Measurement Project, a collaboration among OHSU, OSU-Cascades and the Central Oregon Health Councils to address an area of need identified in their regional health plan in 2020 to 2024, Camilla Dohlman discusses her role and says, "One thing that came through really clearly in the data is that belonging is really a driver of health.”

Medscape publishes a brief about an OHSU patient who is the world's first reported case of brain disease from fentanyl inhalation.

An OHSU study finds that when both cannabis and nicotine are used during pregnancy, the rate of infant death increases fourfold. “With the growing legalization of cannabis around the country, there is often a perception that cannabis is safe in pregnancy,” says Jamie Lo, M.D. "Our hope is that this research supports more open and productive conversations that ultimately result in a healthier pregnancy.”